Fhmls Ix, L.l.c.

PHAT

10% OWNER · PHATHOM PHARMACEUTICALS, INC. · CIK 0001782791

FILING MIX · LIFETIME54%/46%

BUYS

SELLS

TOTAL VALUE

$14.90M

COMPANIES

ACTIVE SINCE

Mar 2020

HOLDINGS NOW

11,244,208

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

1 backtested trades · 8 horizonsHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Fhmls Ix, L.l.c., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	1	+0.00%	-4.79%	-1.50%	-3.28%	-3.28%	—
14d	1	+100.00%	+10.61%	-2.14%	+12.75%	+12.75%	—
30d	1	+100.00%	+10.32%	+4.20%	+6.13%	+6.13%	—
60d	1	+100.00%	+133.95%	+7.97%	+125.97%	+125.97%	—
90d	1	+100.00%	+99.67%	+10.74%	+88.93%	+88.93%	—
180d	1	+100.00%	+31.26%	+21.83%	+9.43%	+9.43%	—
1y	1	+100.00%	+33.99%	+33.61%	+0.38%	+0.38%	—
2y	1	+0.00%	-25.32%	+9.55%	-34.87%	-34.87%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

Not enough transaction history to chart holdings.

Trading cadence · quarterly flow

BUY ● SELL ●

2020

FLOW · 7 buys / 6 sellsCOVERAGE · 4 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
TARS TARSUS PHARMACEUTICALS, INC.	PURCHASE	214,281	—	—	1,604,657	Oct 20, 2020	Oct 20, 2020 ↗	View →
TARS TARSUS PHARMACEUTICALS, INC.	SALE	214,281	—	—	0	Oct 20, 2020	Oct 20, 2020 ↗	View →
TARS TARSUS PHARMACEUTICALS, INC.	SALE	1,390,376	—	—	0	Oct 20, 2020	Oct 20, 2020 ↗	View →
TARS TARSUS PHARMACEUTICALS, INC.	PURCHASE	312,500	$16.00	$5.00M	1,917,157	Oct 20, 2020	Oct 20, 2020 ↗	View →
TARS TARSUS PHARMACEUTICALS, INC.	PURCHASE	1,390,376	—	—	1,390,376	Oct 20, 2020	Oct 20, 2020 ↗	View →
PHAT PHATHOM PHARMACEUTICALS, INC.	SALE	1,456,854	—	—	5,827,415	Jun 12, 2020	Jun 16, 2020 ↗	View →
PASG PASSAGE BIO, INC.	SALE	432,802	—	—	0	Mar 3, 2020	Mar 3, 2020 ↗	View →
PASG PASSAGE BIO, INC.	PURCHASE	550,000	$18.00	$9.90M	5,009,219	Mar 3, 2020	Mar 3, 2020 ↗	View →
PASG PASSAGE BIO, INC.	SALE	1,049,175	—	—	0	Mar 3, 2020	Mar 3, 2020 ↗	View →
PASG PASSAGE BIO, INC.	PURCHASE	2,977,242	—	—	2,977,242	Mar 3, 2020	Mar 3, 2020 ↗	View →
PASG PASSAGE BIO, INC.	SALE	2,977,242	—	—	0	Mar 3, 2020	Mar 3, 2020 ↗	View →
PASG PASSAGE BIO, INC.	PURCHASE	432,802	—	—	4,459,219	Mar 3, 2020	Mar 3, 2020 ↗	View →
PASG PASSAGE BIO, INC.	PURCHASE	1,049,175	—	—	4,026,417	Mar 3, 2020	Mar 3, 2020 ↗	View →

Other insiders · PHAT

Loading peer insiders…

About this filer

CIK 0001782791

ROLE

10% Owner

PRIMARY

PHAT

COMPANIES

ACTIVE SINCE

Mar 2020

MARKETPEEL · /INSIDER/0001782791DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Fhmls Ix, L.l.c.

The morning brief, before the bell.